Navigation Links
Surviving Healthcare Reform: How Biopharma Companies Can Come Out on Top
Date:11/6/2009

STAMFORD, Conn. and WESTON, Mass., Nov. 6 /PRNewswire/ -- Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare reform and maintain attractive long-term returns, according to a white paper published today by Cowen Healthcare Royalty Partners, a global healthcare private equity firm, and Health Advances, a leading healthcare strategy firm.

The paper, "Maintaining Attractive Biopharma Returns in the Face of Healthcare Reform", examines key issues at the center of the debate including access to care, controlling costs, drug pricing and value-based healthcare. In addition to discussing the increased pressures biopharma companies face, including the restrictive use of branded drugs for large patient populations and follow-on biologics, the paper outlines new solutions companies can implement to achieve the same levels of return for its investments as it has in the past.

Some of the paper's key findings include:

  • Biopharma companies need to adapt their business models to maintain attractive ROIs such as exploring pay-for-performance relationships with stakeholders, cost-effective care solutions that align incentives, and investing in follow-on biologics and/or generics
  • Investing in pharmacoeconomic competencies and integrating these into clinical development will mitigate reimbursement risk
  • Investing in personalized healthcare and specifically biomarkers will be rewarded
  • Highly differentiated products addressing niche markets will be the least vulnerable even if stringent regulation is passed

Gregory B. Brown, M.D., Co-Founder and Managing Director of Cowen Royalty, commented, "Healthcare reform is a serious issue for biopharma companies who are already feeling pressure from patent expirations, fewer drug approvals and growing development costs. We partnered with Health Advances to bring a new and unique perspective on the healthcare debate especially as it relates to biopharma companies -- the developers of many of our future medicines."

To download a copy of the white paper visit http://www.cowenroyalty.com/content/news/publications-presentations.htm.

About Cowen Healthcare Royalty Partners:

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purchase of royalty interests. The investment team has over 100 years of healthcare related experience including principal investing, structured finance, healthcare industry senior management, Wall Street research and consulting, scientific and clinical experience. For more information, visit www.cowenroyalty.com.

About Health Advances:

Founded in 1992, Health Advances is a leading healthcare strategy firm advising clients in the biopharma, device and diagnostic sectors. Industry executives and investors rely on Health Advances to advise them on their most challenging commercial decisions. For more information regarding our consulting services, visit www.healthadvances.com.

Media Contact:

    Kellie Walsh
    914-315-6072
    kwalsh@kwmcommunications.com

SOURCE Cowen Healthcare Royalty Partners


'/>"/>
SOURCE Cowen Healthcare Royalty Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chemobrain -- the flip side of surviving cancer
2. More Women Surviving After Early Breast Cancer
3. Early Menstruation Lowers Odds of Surviving Ovarian Cancer
4. More Extreme Preemies Surviving
5. Spike TV Goes Into Production of Special Episode of Original Series Surviving Disaster Focused on the Swine Flu and Other Pandemics
6. Surviving lung cancer
7. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
8. White patients benefit more than blacks in surviving surgical complications at teaching hospitals
9. White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Surviving the Holidays After a Loved Ones Death: Economic Woes Add to Holiday Pressure for People Who Grieve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
Breaking Medicine Technology: